Living With Chronic Lymphocytic Leukemia (CLL)
We invite you to learn more about:
- Treatment goals for a chronic disease
- New and emerging therapies for CLL
- Side-effect management
- The importance of open communication with your healthcare team
Stephen E. Spurgeon, MD
Associate Professor of Medicine
School of Medicine
Oregon Health & Science University
Hematology/Oncology
Portland, OR
Program Support
Support for this program is provided by Genentech, Inc. & Biogen, Eli Lilly and Company, and Pharmacylics, An AbbVie Company & Janssen Biotech.
LLS Fireside Chats for Parents and Caregivers of Young Patients
Did you miss our Fireside Chats? Catch them here!
There are so many questions racing through your mind when your child is diagnosed with a blood cancer. In these videos, hear directly from parents of survivors and learn about The Leukemia & Lymphoma Society's resources and support.
For resources mentioned in these videos, click here.
Program Support
Support for this program is provided by The Leukemia & Lymphoma Society.
Love, Strength, Support: Sibling care in pediatric blood cancer journeys
Program Details
When a family is affected by a pediatric cancer diagnosis, it turns their world upside-down. This can be an especially difficult time for the siblings of pediatric cancer patients. Their family life is altered, and siblings can experience a range of emotions.
Join us for a conversation about how to help your children cope with a sibling’s diagnosis.
Participants will have the opportunity to join our Q&A discussion following the presentation.
Ashleigh Hoying, MHA, CCLS
Certified Child Life Specialist
Cincinnati Children’s Hospital Medical Center
Cincinnati, OH
Mark Smith, LMSW
Adolescent & Young Adult Social Worker
University of Alabama
Birmingham, AL
Professional and parent panel to follow keynote speakers.
Program Support
Support for this program is provided by The Leukemia & Lymphoma Society.
Let’s Talk About CAR T-Cell Therapy as a Treatment Option: Blood Cancers
We invite you to learn more about:
- The process of CAR T-cell therapy
- Eligibility for CAR T-cell therapy
- Side effects and recovery after CAR T-cell therapy
- Maintaining quality of life after CAR T-cell therapy
Monalisa Ghosh, MD
Clinical Associate Professor
University of Michigan Health
Ann Arbor, MI
Program Support
Support for this program is provided by Bristol Myers Squibb; Janssen Oncology & Legend Biotech; and Kite, a Gilead Company.
Coffee With LLS: Let’s Talk About COVID
Please note, with the fast developing knowledge on this topic, some recommendations may change as new data emerges. Click here to access the latest LLS information and resources on COVID-19.
Join LLS as we speak with Dr. Max Brito, professor of medicine in the division of infectious diseases at the University of Illinois at Chicago, Illinois and chief of infectious diseases at the Jesse Brown Veterans Administration Medical Center in Chicago, Illinois. Dr. Brito specializes in the treatment of infectious diseases and in this program he discusses how COVID-19 has affected our blood cancer patients.
This program was originally held in Spanish and has been translated into English.
Max Brito, MD, MPH, FACP, FIDSA
Professor of Medicine
Division of Infectious Diseases
University of Illinois at Chicago (UIC)
Chief of Infectious Diseases
Jesse Brown VA Medical Center
Chicago, Illinois
Program Support
Support for this program provided by BeiGene, Ltd., Bristol Myers Squibb, Kite, A Gilead Company, GSK, Pfizer, and Pharmacyclics, an AbbVie Company & Janssen Biotech.